FDA’s hidden signal greenlights biotech winners — 97% of the time

This is an advertisement. Please read below to find out more! You may [unsubscribe]( at any time. [Stock Pulse News]     FDA’s hidden signal greenlights biotech winners — 97% of the time Dear Reader, The FDA has started to quietly send out a signal … [That has given investors a 97% chance of making money.]( For an average gain of 117% in eight months. Some of the gains have been even more extraordinary … Take Adaptimmune Therapeutics, for example. Shares were hovering around one dollar when the FDA sent out this quiet signal on their new tumor drug. Within six months, shares shot up 845% … Caladrius Biosciences' stock was going nowhere, stuck around $4 … Then it got this FDA signal. And shares jumped 119% — in two days. Ocugen received an FDA signal in December 2023. Its share price spiked 435% in just five months. 63 different publicly traded companies have received 76 of these signals between them in the last seven years. We examined every single one. 97% of them saw the stock price go up in the aftermath. And now, we believe the next FDA signal could come any day … Perhaps as soon as 9:30 a.m. tomorrow. [Click here to find out how you can get in before the FDA's potential signal.]( Sincerely, Michael Robinson, Editor Disruptors & Dominators   This is a third party offer from Weiss Ratings (11780 US Highway 1, Palm Beach Gardens, FL 33408-3080) brought to you by Marketing Tech Solutions. Would you like to [edit your e-mail notification preferences or unsubscribe]( from our mailing list? This email was sent from StockPulseNews.com Altair IDM, Dubai Silicon Oasis, DDP, IFZA Business Park, Building A1, Unit 001, Dubai, United Arab Emirates You may [unsubscribe]( at any time.